pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Dermatology · news · pharmadog
← back to Dermatology
News · Dermatology
112
stories
18d
FDA updates TDS guidances on adhesive performance, skin irritation and sensitization studies
raps
20d
Sanofi to ‘rebuild trust’ with Regeneron; Apnimed adds to string of ‘upsized’ biotech IPOs
biopharma dive
21d
BMS’ ‘big beat’ clouded by Cobenfy, heart disease data delays
biospace
21d
Pfizer's Phase 3 win for Litfulo; Braveheart, Attovia eye IPOs of $275M, $182M
endpoints
21d
Ebola outbreak nears milestone, while a vaccine remains months away
stat
22d
STAT+: FDA expert committee votes in favor of Replimune’s melanoma treatment
stat
22d
Opinion: Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases
stat
22d
STAT+: Latigo reports mid-stage success for would-be rival to Vertex’s pain drug Journavx
stat
22d
Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology push
biopharma dive
22d
Do you need oncology experience to land an oncology job?
biospace
22d
7 companies hiring in New York now
biospace
23d
STAT+: FDA expert panel recommends against approval of Capricor’s Duchenne drug
stat
23d
Opinion: The VA could help America win the biotechnology race with China
stat
23d
STAT+: In the biotech industry, a most-wanted fugitive was long hiding in plain sight
stat
23d
STAT+: American Diabetes Association, facing calls for resignations, asks for patience
stat
23d
STAT+: GSK lays out plans to cut costs, pursue more late-stage drug trials
stat
23d
STAT+: FDA staff reiterate concerns about Replimune skin cancer treatment
stat
23d
Altimmune rises as GLP-1/glucagon drug curbs heavy drinking in mid-stage study
biospace
24d
After PCOS became PMOS, there’s hope for new awareness among Black and Latina women
stat
24d
Argenx to acquire Forte in $2.2B deal for ‘differentiated’ immune drug
biopharma dive
25d
InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test
fiercebiotech
27d
Sanofi halts development of troubled immune drug in eczema
biopharma dive
27d
Sanofi’s $1.4B Kymab bet falters again as atopic dermatitis trials scrapped
biospace
28d
Sanofi nixes Kymab-originated OX40L antibody in atopic dermatitis
endpoints
28d
FDA panel endorses broader use of certain peptides
biopharma dive
29d
Arrowhead hits ‘best-case scenario’ with latest results for fat-lowering drug
biopharma dive
29d
STAT+: Pharma tries to tamp down broad China restrictions
stat
29d
Summit counters PD-1/VEGF skeptics; Celldex drug fails skin disease study
biopharma dive
29d
Celldex scraps antibody in prurigo nodularis after Phase 2 flop
endpoints
Jul 22, 26
As Maui recovers from devastating fires, a study offers vision for new rural health model
stat
← prev
page 2 of 4
next →
